NIGHTHAWK BIOSCIENCES INC (NHWK) Stock Price & Overview
NYSEARCA:NHWK • US42237K4094
The current stock price of NHWK is 0.4135 USD. Today NHWK is up by 8.96%. In the past month the price decreased by -8.05%. In the past year, price decreased by -60.24%.
NHWK Key Statistics
- Market Cap
- 36.338M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.98
- Dividend Yield
- N/A
NHWK Stock Performance
NHWK Stock Chart
NHWK Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to NHWK. When comparing the yearly performance of all stocks, NHWK is a bad performer in the overall market: 90.35% of all stocks are doing better.
NHWK Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NHWK. NHWK has a bad profitability rating. Also its financial health evaluation is rather negative.
NHWK Earnings
NHWK Forecast & Estimates
6 analysts have analysed NHWK and the average price target is 10.2 USD. This implies a price increase of 2366.75% is expected in the next year compared to the current price of 0.4135.
For the next year, analysts expect an EPS growth of -16.18% and a revenue growth -28.99% for NHWK
NHWK Groups
Sector & Classification
NHWK Financial Highlights
Over the last trailing twelve months NHWK reported a non-GAAP Earnings per Share(EPS) of -1.98. The EPS decreased by -21.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -74.32% | ||
| ROE | -143.11% | ||
| Debt/Equity | 0.25 |
NHWK Ownership
NHWK Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16 | 417.437B | ||
| AMGN | AMGEN INC | 16.31 | 204.229B | ||
| GILD | GILEAD SCIENCES INC | 16.27 | 183.894B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.6 | 121.25B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.47 | 83.255B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 47.84 | 43.24B | ||
| INSM | INSMED INC | N/A | 31.965B | ||
| NTRA | NATERA INC | N/A | 28.775B | ||
| BIIB | BIOGEN INC | 12.36 | 27.876B | ||
| MRNA | MODERNA INC | N/A | 22.581B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.24 | 21.486B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 20.053B | ||
| EXAS | EXACT SCIENCES CORP | 308.82 | 19.749B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NHWK
Company Profile
NightHawk Biosciences, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in Morrisville, North Carolina and currently employs 77 full-time employees. The company went IPO on 2013-07-24. Scorpius offers an array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its clinical biomanufacturing capabilities include cGMP Mammalian Cell Culture and cGMP Microbial Fermentation. Its process development includes mammalian cell culture development, cell therapy development, microbial fermentation development, downstream process development and formulation development. The company also offers bioanalytical services, analytical methods development, pre-clinical and product development services, CMC analytical support services, bioassays and analytical technologies.
Company Info
NIGHTHAWK BIOSCIENCES INC
627 Davis Drive, Suite 300
Morrisville NORTH CAROLINA US
Employees: 77
Phone: 19192407133
NIGHTHAWK BIOSCIENCES INC / NHWK FAQ
What does NIGHTHAWK BIOSCIENCES INC do?
NightHawk Biosciences, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in Morrisville, North Carolina and currently employs 77 full-time employees. The company went IPO on 2013-07-24. Scorpius offers an array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its clinical biomanufacturing capabilities include cGMP Mammalian Cell Culture and cGMP Microbial Fermentation. Its process development includes mammalian cell culture development, cell therapy development, microbial fermentation development, downstream process development and formulation development. The company also offers bioanalytical services, analytical methods development, pre-clinical and product development services, CMC analytical support services, bioassays and analytical technologies.
What is the current price of NHWK stock?
The current stock price of NHWK is 0.4135 USD. The price increased by 8.96% in the last trading session.
Does NIGHTHAWK BIOSCIENCES INC pay dividends?
NHWK does not pay a dividend.
How is the ChartMill rating for NIGHTHAWK BIOSCIENCES INC?
NHWK has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the valuation of NIGHTHAWK BIOSCIENCES INC (NHWK) based on its PE ratio?
NIGHTHAWK BIOSCIENCES INC (NHWK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.98).
Is NIGHTHAWK BIOSCIENCES INC (NHWK) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NHWK.
What is the employee count for NHWK stock?
NIGHTHAWK BIOSCIENCES INC (NHWK) currently has 77 employees.